Abiopharma

🔍 Bo-Linn Cheemin (Director)

Company: Silvaco Group, Inc. (SVCO)

Report Date: 2026-08-11

Detailed Transactions and Holdings:

• Acquired 1,400 shares of Common Stock (Direct)
  Date: 2026-08-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 18,964.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 700 shares of Common Stock at $7.2755 per share (Direct)
  Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 18,264.00 | transaction_form_type: 4 | Footnotes: F2, F3

Footnotes:

• F1: The shares of Silvaco Group, Inc. (the "Issuer") common stock were awarded to the Reporting Person pursuant to an amendment to the Issuer's non-employee director compensation plan providing for the replacement of the quarterly cash retainer earned in the second quarter of fiscal 2026 with an award of Issuer common stock with a fair market value equal to such quarterly cash retainer.
• F2: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.25 to $7.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.